Your browser doesn't support javascript.
loading
Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?
Sørensen, Brita S; Pawelke, Jörg; Bauer, Julia; Burnet, Neil G; Dasu, Alexandru; Høyer, Morten; Karger, Christian P; Krause, Mechthild; Schwarz, Marco; Underwood, Tracy S A; Wagenaar, Dirk; Whitfield, Gillian A; Lühr, Armin.
Afiliación
  • Sørensen BS; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; Experimental Clinical Oncology - Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: bsin@oncology.au.dk.
  • Pawelke J; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Institute of Radiooncology-OncoRay, Dr
  • Bauer J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
  • Burnet NG; The Christie NHS Foundation Trust, Manchester, UK.
  • Dasu A; The Skandion Clinic, Uppsala, Sweden; Medical Radiation Sciences, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Høyer M; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Karger CP; Dept. of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
  • Krause M; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Institute of Radiooncology-OncoRay, Dr
  • Schwarz M; Protontherapy Department -Trento Hospital, and TIFPA-INFN, Trento, Italy.
  • Underwood TSA; Division of Cancer Sciences, School of Medical Sciences, The University of Manchester, UK.
  • Wagenaar D; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Whitfield GA; The Christie NHS Foundation Trust, Manchester, UK; University of Manchester, UK.
  • Lühr A; Department of Physics, TU Dortmund University, Dortmund, Germany.
Radiother Oncol ; 163: 177-184, 2021 10.
Article en En | MEDLINE | ID: mdl-34480959
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia de Protones Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia de Protones Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Irlanda